Clinical Trial

Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)

Name: Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP) — clinical trial record (NCT05552755)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TUPELO

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a multicenter, two-part trial in participants with FAP.

Protocol Amendment History 23 amendments

This ClinicalTrials.gov record has been amended 23 times since 2022-09-20; most recent amendment 2026-06-03.

Status change: Not Yet Recruiting → Recruiting 2022-09-27

Trial Details

NCT Number	NCT05552755
Lead Sponsor	Recursion Pharmaceuticals Inc.
Conditions	Familial Adenomatous Polyposis
Enrollment	67 participants
Start Date	2023-07-10
Primary Completion	2027-06 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2026-06-05